Skip to main content
. 2020 Jul 9;19:102. doi: 10.1186/s12904-020-00606-0

Table 1.

Characteristics of patient participants (N = 120)

N = 120
Demographics n (%)
Age 30–39 7 (5.8)
(56.6 ± SD 11.57) 40–49 28 (23.4)
50–59 33 (27.5)
60–69 30 (25.0)
70–89 22 (18.3)
Sex Male 25 (20.8)
Female 95 (79.2)
Highest education level Middle/High school 32 (26.7)
Vocational school/jr. college 43 (35.8)
University/graduate school 45 (37.5)
Disease n (%)
Diagnosis Breast 85 (70.8)
Digestive system 22 (18.3)
Urological 11 (9.2)
Other 2 (1.7)
Stage Stage IV 111 (92.5)
Stage IIIc 6 (5.0)
Stage IIIb 3 (2.5)
Metastasis Yes 110 (91.7)
(Bone metastasis) 67 (57.5)
No 10 (8.3)
PS a 0 73 (60.8)
1 40 (33.3)
2 7 (5.8)
Drugs used No analgesics usedb 46 (38.3)
Non-opioids 57 (46.6)
Weak opioids 7 (5.8)
Strong opioids 26 (21.7)

a Eastern Cooperative Oncology Group performance status

b This category includes “Analgesics prescribed but patient has elected not to use,” “Experiencing pain but no analgesics prescribed,” and “Had no pain on the day of the survey”